SUPERIOR QUALITY PRENATAL SCREENING
The FERTILYS prenatal screening model ensures superior quality
It is important to mention that in terms of knowledge and skill, FERTILYS is of the same school of thought that the Fetal Medicine Foundation (FMF, London, England). The FMF advocates for a prenatal testing model based on preventive medicine, which involves a superior approach focused on the well-being of couples and their children. It provides a prenatal screening model applied early in pregnancy (between 11 and 14 weeks).
FERTILYS uses a prenatal screening model based on a detailed fetal anatomy assessment that goes well beyond Down’s syndrome, testing for fetal heart defects, the risk for intrauterine fetal growth retardation and preterm labor. Screening also predicts the maternal risk of pre-eclampsia and hypertension during pregnancy.
Regarding testing for Down’s syndrome, trisomy 18 and 13, the FERTILYS program is not limited to the nuchal translucency test. It also includes around other powerful ultrasound markers such as nasal bone, ductus venosus and tricuspid valve flow and fetal heart rate, which make screening much more effective. Read more on the Fetal Medicine Foundation website.
N.B. Screening indicates the level of risk and whether there is a need to carry out a diagnostic test like an amniocentesis at the 15th week of pregnancy. It can also determine whether to perform a biopsy of the trophoblast (chorionic villus sampling from the placenta), which is done earlier, at the 11th week of pregnancy. For women with an intermediate risk (1:100 – 1:1000), a high quality test detecting fetal DNA circulating freely in maternal blood is also always available at FERTILYS.